Abstract
Crohn9s disease (CD) is a chronic inflammatory condition of the gastrointestinal tract. Individuals with CD present with acute inflammatory exacerbations as well as acute and chronic complications. Management requires specialist input from gastroenterologists, colorectal surgeons, nurse specialists and pharmacists as well as general and primary care physicians to allow appropriate selection of treatment options including surgery and rapid assessment and treatment of those with acute exacerbations. Monitoring of the individual and their medication is crucial in preventing and recognising complications including those associated with treatment. This concise guideline focuses on recommendations from National Institute for Health and Care Excellence (NICE) ­Clinical ­Guideline 152 (CG152) considered of key importance for implementation.
Funding Information
  • China Middle-young VG Clinical Research Fund (2017-CCA-VG-047)
  • National Key Research and Development Plan of China (2019YFC0118203, 2016YFC130640)
  • the Natural Science Foundation of Zhejiang Province, China (LR20H180001)
  • National Natural Science Foundation of China (81873894)
  • Zhejiang Key Research and Development Plan (2017C03011)